aTyr Pharma ATYR Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's total liabilities & equity?
- aTyr Pharma (ATYR) reported total liabilities & equity of $79.65M in Q1 2026.
- How has aTyr Pharma's total liabilities & equity changed year-over-year?
- aTyr Pharma's total liabilities & equity decreased by 18.1% year-over-year, from $97.25M to $79.65M.
- What is the long-term trend for aTyr Pharma's total liabilities & equity?
- Over 5 years (2020 to 2025), aTyr Pharma's total liabilities & equity has grown at a 19.2% compound annual growth rate (CAGR), from $38.73M to $93M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.